These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9580090

  • 1. Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.
    Steegmann JL, Granados E, Peñarrubia MJ.
    Haematologica; 1997; 82(6):731-2. PubMed ID: 9580090
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
    Bogdanov KV, Frolova OI, Marinets OV, Ogorodnikova IuS, Afanas'ev BV, Zaritskiĭ AIu.
    Vopr Onkol; 2003; 49(2):189-92. PubMed ID: 12785203
    [Abstract] [Full Text] [Related]

  • 6. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
    Canales MA, Martínez J, Quevedo E, Hernández-Navarro F.
    Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase.
    Guilhot F, Lacotte-Thierry L.
    Hematol Cell Ther; 1998 Oct; 40(5):237-9. PubMed ID: 9844819
    [Abstract] [Full Text] [Related]

  • 9. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders].
    Skotnicki AB, Wolska-Smoleń T.
    Acta Haematol Pol; 1994 Oct; 25(2 Suppl 1):124-35. PubMed ID: 8067197
    [Abstract] [Full Text] [Related]

  • 10. [Alpha-interferons in the treatment of patients with chronic myeloid leukemia].
    Abdulkadyrov KM, Udal'eva VIu, Rukavitsyn OA, Bessmel'tsev SS.
    Vopr Onkol; 1999 Oct; 45(4):387-92. PubMed ID: 10532097
    [Abstract] [Full Text] [Related]

  • 11. Is imatinib a cost-effective treatment for newly diagnosed chronic myeloid leukemia patients?
    Goldman J.
    Nat Clin Pract Oncol; 2005 Mar; 2(3):126-7. PubMed ID: 16264901
    [No Abstract] [Full Text] [Related]

  • 12. The role of interferon-alpha in the treatment of chronic myeloid leukemia.
    Kujawski LA, Talpaz M.
    Cytokine Growth Factor Rev; 2007 Mar; 18(5-6):459-71. PubMed ID: 17703986
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience of antibodies to interferon-alpha during treatment of chronic myeloid leukemia.
    Russo D, Candoni A, Grattoni R.
    J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S47-9. PubMed ID: 9241616
    [Abstract] [Full Text] [Related]

  • 14. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
    Mesquita MM, Pestana A, Mota A.
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
    [No Abstract] [Full Text] [Related]

  • 15. Interferon alpha in the treatment of chronic myelogenous leukemia.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1998 Mar; 46(6):347-53. PubMed ID: 9883313
    [Abstract] [Full Text] [Related]

  • 16. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY, Marley SB, Lewis JL, Davidson RJ, Nguyen DX, Grand FH, Amos TA, Goldman JM.
    J Clin Invest; 1998 Aug 15; 102(4):710-5. PubMed ID: 9710439
    [Abstract] [Full Text] [Related]

  • 17. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F.
    Rev Prat; 1999 Mar 01; 49(5):464-6. PubMed ID: 10358394
    [No Abstract] [Full Text] [Related]

  • 18. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
    Kantarjian HM, O'Brien S, Cortes J, Giles FJ, Rios MB, Shan J, Faderl S, Garcia-Manero G, Ferrajoli A, Verstovsek S, Wierda W, Keating M, Talpaz M.
    Cancer; 2003 Dec 15; 98(12):2636-42. PubMed ID: 14669283
    [Abstract] [Full Text] [Related]

  • 19. [Interferon and chronic myeloid leukemia].
    Steegmann JL, Pérez Sánchez M, Fernández-Rañada JM.
    Sangre (Barc); 1990 Jun 15; 35(3):213-7. PubMed ID: 2204124
    [No Abstract] [Full Text] [Related]

  • 20. Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia.
    Steegmann JL, Moreno G, Aláez C, Osorio S, Granda A, de la Cámara R, Arranz E, Reino FG, Salvanés FR, Fernández-Rañada JM, Muñoz C.
    Haematologica; 2003 Jul 15; 88(7):762-8. PubMed ID: 12857554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.